Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
Launched by M.D. ANDERSON CANCER CENTER · Aug 5, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to see how a special yoga therapy program can help women with ovarian cancer who are about to start chemotherapy and then have surgery. The researchers want to find out if this yoga program can improve the quality of life for these patients and help with other health-related outcomes. The trial is not yet recruiting participants, but when it starts, it will focus on women aged 18 and older who have certain types of advanced ovarian cancer and are planning to have surgery at MD Anderson Cancer Center.
To be eligible for the trial, participants should be able to read, write, and speak English, have access to the internet and a device like a tablet or smartphone, and have a good level of physical ability. However, women who have already completed chemotherapy, have severe communication difficulties, or major mobility issues won't be able to join. Participants can expect to engage in a structured yoga program designed specifically for their needs, which may help them feel better during their cancer treatment journey.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Women with stage III-IV epithelial ovarian, fallopian tube, primary peritonal cancer with recommendations for NACT/IDS at recruitment.
- • 2. Able to read, write, and speak English.
- • 3. 18 years of age or older.
- • 4. Oriented to person, place, and time.
- • 5. Access to internet connection.
- • 6. Access to a tablet, laptop or computer or smart phone.
- • 7. Plan for surgical intervention at MD Anderson Cancer Center
- • 8. Performance status 0-2.
- Exclusion Criteria:
- • 1. Have completed chemotherapy.
- • 2. Any major thought disorder (e.g., schizophrenia, dementia).
- • 3. Any major communication barriers that would preclude being able to complete the intervention (e.g., visually or hearing impaired).
- • 4. Extreme mobility issues (e.g., unable to get in and out of a chair unassisted).
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Lois Ramondetta, MD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported